Table 5.
Factors Associated With Treatment Incompletion (N=1489)
| Characteristic | Incompletion, % |
OR (95% CI) | P * |
|---|---|---|---|
| Age group, y | |||
| <50 | 10 | Referent | |
| 50-59 | 10.6 | 1.11 (0.70-1.75) | .651 |
| 60-69 | 11.7 | 1.21 (0.77-1.89) | .412 |
| ≥70 | 25.2 | 2.94 (1.85-4.66) | <.001 |
| Performance status | |||
| 0 | 9.2 | Referent | |
| 1 | 13.9 | 1.48 (1.03-2.12) | .033 |
| 2 | 22 | 2.59 (1.58-4.25) | <.001 |
| Stage/debulking | |||
| III, microscopic | 12.7 | Referent | |
| III, optimal | 14.1 | 1.22 (0.78-1.91) | .388 |
| III, suboptimal | 9.4 | 0.69 (0.43-1.13) | .138 |
| IV | 17.7 | 1.29 (0.78-2.15) | .324 |
| Histology | |||
| Serous | 13.1 | Referent | |
| Endometrioid | 9.5 | 0.65 (0.35-1.23) | .187 |
| Mucinous | 33.3 | 4.05 (1.78-9.22) | <.001 |
| Clear cell | 20.5 | 1.84 (0.84-4.03) | .127 |
| Other | 9.5 | 0.68 (0.40-1.14) | .140 |
| Race | |||
| White | 12.9 | Referent | |
| Black | 13.4 | 0.96 | .899 |
OR indicates odds ratio; CI, confidence interval.
*
ORs were estimated by using a logistic regression model adjusted for covariates.